| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Mai―01 |
A Novel Covalent Inhibitor Fragment for the SARS-CoV-2 Main Protease Identified by Target-Specific Deep Learning |
Weijun Zhou, Angel D′Oliviera, Xuhang Dai, Jeffrey S. Mugridge, Yingkai Zhang |
| 2 |
[GO] |
2025―Sep―01 |
Time-Resolved Analysis of Protein-Protein Ensembles Using a Destabilizing Domain to Map Dynamic Interactions of SARS-CoV-2 nsp15 |
Crissey Cameron, R. Mason Clark, Adam M. Metts, Runze M. Jiang, Toya D. Scaggs, Kwangho Kim, Gary A. Sulikowski, Lars Plate |
| 3 |
[GO] |
2025―Jul―07 |
SARS-CoV-2 Omicron Variant Spike Glycoprotein Mutation Q954H Enhances Fusion Core Stability |
Nisansala Vithanage, Rifat Hasan Apurba, Hamza Enesi Ozomarisi, Carson J. Bair, Eve L. Sugg, Victor K. Outlaw |
| 4 |
[GO] |
2025―Mai―13 |
Identification of an Unnatural Sulfated Monosaccharide as a High-Affinity Ligand for Pan-Variant Targeting of SARS-CoV-2 Spike Glycoprotein |
Ally Thompson, Nehru Viji Sankaranarayanan, John E. Chittum, Virendrasinh Mahida, Sharath S. Vishweshwara, Rakesh Raigawali, Saurabh Anand, Raghavendra Kikkeri, Umesh R. Desai |
| 5 |
[GO] |
2025―Apr―24 |
Neurotoxic Implications of Human Coronaviruses in Neurodegenerative Diseases: A Perspective from Amyloid Aggregation |
Thi Hong Van Nguyen, Francois Ferron, Kazuma Murakami |
| 6 |
[GO] |
2025―Feb―06 |
Analogs of NIH Molecular Probe ML283 Are Potent SARS-CoV-2 Helicase Inhibitors |
David N. Frick, Robert V. Bavisotto, Nicholas C. Hopper, Wilfred T. Tysoe |
| 7 |
[GO] |
2024―Jul―09 |
A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13 |
Nathan Soper, Isabelle Yardumian, Eric Chen, Chao Yang, Samantha Ciervo, Aaron L. Oom, Ludovic Desvignes, Mark J. Mulligan, Yingkai Zhang, Tania J. Lupoli |
| 8 |
[GO] |
2024―Jun―12 |
High-Resolution Substrate Specificity Profiling of SARS-CoV-2 Mpro; Comparison to SARS-CoV Mpro |
Rasha M. Yaghi, Collin L. Andrews, Dennis C. Wylie, Brent L. Iverson |
| 9 |
[GO] |
2024―Apr―26 |
Detection of Active SARS-CoV-2 3CL Protease in Infected Cells Using Activity-Based Probes with a 2,6-Dichlorobenzoyloxymethyl Ketone Reactive Warhead |
Yuki Yamauchi, Sho Konno, Noriko Omura, Narumi Yoshioka, Alexandra Hingst, Michael Gütschow, Christa E. Müller, Akihiro Taguchi, Atsuhiko Taniguchi, Atsushi Kawaguchi, Yoshio Hayashi |
| 10 |
[GO] |
2024―Apr―22 |
GS-441524-Diphosphate-Ribose Derivatives as Nanomolar Binders and Fluorescence Polarization Tracers for SARS-CoV-2 and Other Viral Macrodomains |
Kewen Peng, Shamar D. Wallace, Saket R. Bagde, Jialin Shang, Ananya Anmangandla, Sadhan Jana, J. Christopher Fromme, Hening Lin |
| 11 |
[GO] |
2024―Mrz―27 |
Correction to “A Fluorescence Polarization Assay for Macrodomains Facilitates the Identification of Potent Inhibitors of the SARS-CoV-2 Macrodomain” |
Ananya Anmangandla, Sadhan Jana, Kewen Peng, Shamar D. Wallace, Saket R. Bagde, Bryon S. Drown, Jiashu Xu, Paul J. Hergenrother, J. Christopher Fromme, Hening Lin |
| 12 |
[GO] |
2023―Dez―27 |
Allosteric Inhibitors of the SARS-COV-2 Papain-like Protease Domain Induce Proteasomal Degradation of Its Parent Protein NSP3 |
Peter E. Cockram, Benjamin T. Walters, Aaron Lictao, Frances Shanahan, Ingrid E. Wertz, Scott A. Foster, Joachim Rudolph |
| 13 |
[GO] |
2023―Dez―12 |
Discovery of High Affinity Cyclic Peptide Ligands for Human ACE2 with SARS-CoV-2 Entry Inhibitory Activity |
Max J. Bedding, Charlotte Franck, Jason Johansen-Leete, Anupriya Aggarwal, Joshua W. C. Maxwell, Karishma Patel, Paige M. E. Hawkins, Jason K. K. Low, Rezwan Siddiquee, Hakimeh Moghaddas Sani, Daniel J. Ford, Stuart Turville, Joel P. Mackay, Toby Passioura, Mary Christie, Richard J. Payne |
| 14 |
[GO] |
2023―Mai―01 |
A Fluorescence Polarization Assay for Macrodomains Facilitates the Identification of Potent Inhibitors of the SARS-CoV-2 Macrodomain |
Ananya Anmangandla, Sadhan Jana, Kewen Peng, Shamar D. Wallace, Saket R. Bagde, Bryon S. Drown, Jiashu Xu, Paul J. Hergenrother, J. Christopher Fromme, Hening Lin |
| 15 |
[GO] |
2023―Apr―27 |
SARS-CoV-2 Spike N-Terminal Domain Engages 9-O-Acetylated α2-8-Linked Sialic Acids |
Ilhan Tomris, Luca Unione, Linh Nguyen, Pouya Zaree, Kim M. Bouwman, Lin Liu, Zeshi Li, Jelle A. Fok, María Ríos Carrasco, Roosmarijn van der Woude, Anne L. M. Kimpel, Mirte W. Linthorst, Sinan E. Kilavuzoglu, Enrico C. J. M. Verpalen, Tom G. Caniels, Rogier W. Sanders, Balthasar A. Heesters, Roland J. Pieters, Jesús Jiménez-Barbero, John S. Klassen, Geert-Jan Boons, Robert P. de Vries |
| 16 |
[GO] |
2023―Apr―03 |
Adjuvant-Free COVID-19 Vaccine with Glycoprotein Antigen Oxidized by Periodate Rapidly Elicits Potent Immune Responses |
Ru-Yan Zhang, Shi-Hao Zhou, Ran-Ran Feng, Yu Wen, Dong Ding, Zhi-Ming Zhang, Hua-Wei Wei, Jun Guo |
| 17 |
[GO] |
2023―Jan―17 |
Discovery of All-d-Peptide Inhibitors of SARS-CoV-2 3C-like Protease |
Raphael J. Eberle, Marc Sevenich, Ian Gering, Lara Scharbert, Birgit Strodel, Nils A. Lakomek, Karoline Santur, Jeannine Mohrlüder, Mônika A. Coronado, Dieter Willbold |
| 18 |
[GO] |
2023―Jan―11 |
A Novel Y-Shaped, S-O-N-O-S-Bridged Cross-Link between Three Residues C22, C44, and K61 Is Frequently Observed in the SARS-CoV-2 Main Protease |
Kai S. Yang, Lauren R. Blankenship, Syuan-Ting Alex Kuo, Yan J. Sheng, Pingwei Li, Carol A. Fierke, David H. Russell, Xin Yan, Shiqing Xu, Wenshe Ray Liu |
| 19 |
[GO] |
2022―Sep―29 |
Novel Regioselective Approach to Cyclize Phage-Displayed Peptides in Combination with Epitope-Directed Selection to Identify a Potent Neutralizing Macrocyclic Peptide for SARS-CoV-2 |
J. Trae Hampton, Tyler J. Lalonde, Jeffery M. Tharp, Yadagiri Kurra, Yugendar R. Alugubelli, Christopher M. Roundy, Gabriel L. Hamer, Shiqing Xu, Wenshe Ray Liu |
| 20 |
[GO] |
2022―Jun―22 |
Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants |
Jonathan M. Labriola, Shane Miersch, Gang Chen, Chao Chen, Alevtina Pavlenco, Reza Saberianfar, Francesca Caccuri, Alberto Zani, Nitin Sharma, Annie Feng, Daisy W. Leung, Arnaldo Caruso, Giuseppe Novelli, Gaya K. Amarasinghe, Sachdev S. Sidhu |
| 21 |
[GO] |
2022―Mrz―26 |
Detection of SARS-CoV-2 RNA Using a DNA Aptamer Mimic of Green Fluorescent Protein |
Bria S. VarnBuhler, Jared Moon, Sourav Kumar Dey, Jiahui Wu, Samie R. Jaffrey |
| 22 |
[GO] |
2021―Dez―14 |
High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain |
Morgan Dasovich, Junlin Zhuo, Jack A. Goodman, Ajit Thomas, Robert Lyle McPherson, Aravinth Kumar Jayabalan, Veronica F. Busa, Shang-Jung Cheng, Brennan A. Murphy, Karli R. Redinger, Yousef M. O. Alhammad, Anthony R. Fehr, Takashi Tsukamoto, Barbara S. Slusher, Jürgen Bosch, Huijun Wei, Anthony K. L. Leung |
| 23 |
[GO] |
2021―Nov―18 |
Clinical Antiviral Drug Arbidol Inhibits Infection by SARS-CoV-2 and Variants through Direct Binding to the Spike Protein |
Anton Shuster, Dany Pechalrieu, Cody B Jackson, Daniel Abegg, Hyeryun Choe, Alexander Adibekian |
| 24 |
[GO] |
2021―Jul―30 |
The SARS-CoV-2 Programmed -1 Ribosomal Frameshifting Element Crystal Structure Solved to 2.09 Å Using Chaperone-Assisted RNA Crystallography |
Christina Roman, Anna Lewicka, Deepak Koirala, Nan-Sheng Li, Joseph A. Piccirilli |
| 25 |
[GO] |
2021―Jul―04 |
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies |
Yury Valdes-Balbin, Darielys Santana-Mederos, Lauren Quintero, Sonsire Fernández, Laura Rodriguez, Belinda Sanchez Ramirez, Rocmira Perez-Nicado, Claudia Acosta, Yanira Méndez, Manuel G. Ricardo, Tays Hernandez, Gretchen Bergado, Franciscary Pi, Annet Valdes, Tania Carmenate, Ubel Ramirez, Reinaldo Oliva, Jean-Pierre Soubal, Raine Garrido, Felix Cardoso, Mario Landys, Humberto Gonzalez, Mildrey Farinas, Juliet Enriquez, Enrique Noa, Anamary Suarez, Cheng Fang, Luis A. Espinosa, Yassel Ramos, Luis Javier González, Yanet Climent, Gertrudis Rojas, Ernesto Relova-Hernández, Yanelys Cabrera Infante, Sum Lai Losada, Tammy Boggiano, Eduardo Ojito, Kalet León, Fabrizio Chiodo, Françoise Paquet, Guang-Wu Chen, Daniel G. Rivera, Dagmar Garcia-Rivera, Vicente Verez Bencomo |
| 26 |
[GO] |
2021―Mrz―31 |
A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells |
Drake M. Mellott, Chien-Te Tseng, Aleksandra Drelich, Pavla Fajtová, Bala C. Chenna, Demetrios H. Kostomiris, Jason Hsu, Jiyun Zhu, Zane W. Taylor, Klaudia I. Kocurek, Vivian Tat, Ardala Katzfuss, Linfeng Li, Miriam A. Giardini, Danielle Skinner, Ken Hirata, Michael C. Yoon, Sungjun Beck, Aaron F. Carlin, Alex E. Clark, Laura Beretta, Daniel Maneval, Vivian Hook, Felix Frueh, Brett L. Hurst, Hong Wang, Frank M. Raushel, Anthony J. O’Donoghue, Jair Lage de Siqueira-Neto, Thomas D. Meek, James H. McKerrow |
| 27 |
[GO] |
2021―Feb―15 |
Development of a Broadly Applicable Cas12a-Linked Beam Unlocking Reaction for Sensitive and Specific Detection of Respiratory Pathogens Including SARS-CoV-2 |
Yu Wang, Donglan Liu, Huihuang Lin, Dingbin Chen, Jing Sun, Yusang Xie, Xinjie Wang, Peixiang Ma, Yan Nie, Hong Mei, Baihui Zhao, Xingxu Huang, Ge Jiang, Xianxing Jiang, Jieming Qu, Jincun Zhao, Jia Liu |
| 28 |
[GO] |
2020―Jun―25 |
Scientific Response to the Coronavirus Crisis in Spain: Collaboration and Multidisciplinarity |
Oscar Millet, Aitziber L. Cortajarena, Xavier Salvatella, Jesús Jiménez-Barbero |
| 29 |
[GO] |
2020―Mai―08 |
When the Others Become Us: A Chemist’s Perspective of the COVID-19 Outbreak in Italy |
Laura Kiessling, Christina MacLaughlin, Sara Sattin |
| 30 |
[GO] |
2020―Apr―01 |
Fighting the Coronavirus Outbreak |
Laura Kiessling, Peng Chen, Jie Wang, Jie P. Li |
|
